Wang LG et al. |
Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. |
2004 |
Oncogene |
pmid:15156193
|
Yokota T et al. |
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. |
2004 |
Oncogene |
pmid:15107822
|
Suzuki M et al. |
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. |
2006 |
Oncogene |
pmid:16331260
|
McGarry LC et al. |
Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. |
2004 |
Oncogene |
pmid:15107823
|
Guo WH et al. |
Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. |
2002 |
Oncogene |
pmid:12447699
|
Su SF et al. |
miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. |
2013 |
Oncogene |
pmid:23085757
|
Ong DC et al. |
LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. |
2009 |
Oncogene |
pmid:19734946
|
Tessema M et al. |
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. |
2010 |
Oncogene |
pmid:20562917
|
Vincent A et al. |
Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. |
2007 |
Oncogene |
pmid:17471237
|
Augenlicht L et al. |
Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. |
2003 |
Oncogene |
pmid:12902981
|
Zhong S et al. |
Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. |
2003 |
Oncogene |
pmid:12917630
|
Mühlisch J et al. |
Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. |
2006 |
Oncogene |
pmid:16186793
|
Cismasiu VB et al. |
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. |
2005 |
Oncogene |
pmid:16091750
|
Cras A et al. |
Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. |
2007 |
Oncogene |
pmid:17213810
|
Karagiannis TC et al. |
Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. |
2007 |
Oncogene |
pmid:17213813
|
Sengupta S et al. |
Tumor suppressor p53 represses transcription of RECQ4 helicase. |
2005 |
Oncogene |
pmid:15674334
|
Busson M et al. |
Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. |
2005 |
Oncogene |
pmid:15674337
|
López-Soto A et al. |
HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. |
2009 |
Oncogene |
pmid:19430493
|
Sengupta S et al. |
Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. |
2011 |
Oncogene |
pmid:20856196
|
Kim YB et al. |
Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. |
1999 |
Oncogene |
pmid:10229197
|
Shin HJ et al. |
Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. |
2003 |
Oncogene |
pmid:12813458
|
Chan AS et al. |
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. |
2003 |
Oncogene |
pmid:14534543
|
Krishnan M et al. |
HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. |
2010 |
Oncogene |
pmid:19881542
|
Shteper PJ et al. |
Role of promoter methylation in regulation of the mammalian heparanase gene. |
2003 |
Oncogene |
pmid:14586400
|
Hirose T et al. |
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. |
2003 |
Oncogene |
pmid:14586402
|
Meng Z et al. |
PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition. |
2016 |
Oncogene |
pmid:26279303
|
Ibanez de Caceres I et al. |
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. |
2010 |
Oncogene |
pmid:20023704
|
Zubia A et al. |
Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. |
2009 |
Oncogene |
pmid:19169274
|
Kumar KS et al. |
Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. |
2006 |
Oncol. Rep. |
pmid:17016591
|
Kang FW et al. |
Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. |
2012 |
Oncol. Rep. |
pmid:22552321
|
Meng J et al. |
The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. |
2012 |
Oncol. Rep. |
pmid:22552631
|
Rhodes LV et al. |
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. |
2012 |
Oncol. Rep. |
pmid:21971930
|
Kim SH et al. |
Regulation of the HIF-1alpha stability by histone deacetylases. |
2007 |
Oncol. Rep. |
pmid:17273746
|
Ganslmayer M et al. |
A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells. |
2004 |
Oncol. Rep. |
pmid:15069530
|
Wang B et al. |
Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. |
2014 |
Oncol. Rep. |
pmid:25224651
|
Um SJ et al. |
In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group. |
2004 |
Oncol. Rep. |
pmid:14767528
|
Wu DS et al. |
Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a. |
2013 |
Oncol. Rep. |
pmid:24064951
|
Nakajima S et al. |
Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231. |
2009 |
Oncol. Rep. |
pmid:19513516
|
Zuo X et al. |
Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. |
2014 |
Oncol. Rep. |
pmid:24676336
|
Yanada M et al. |
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. |
2005 |
Oncol. Rep. |
pmid:16142337
|
Jia L et al. |
Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR‑375. |
2017 |
Oncol. Rep. |
pmid:27878285
|
Zhang NH et al. |
Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells. |
2016 |
Oncol. Rep. |
pmid:27373420
|
Qiao F et al. |
Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. |
2012 |
Oncol. Rep. |
pmid:22825043
|
Liu Z et al. |
Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. |
2008 |
Oncol. Rep. |
pmid:18575731
|
Wang SC et al. |
Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1‑survivin downregulation at the late phase of treatment. |
2017 |
Oncol. Rep. |
pmid:28713892
|
Puppin C et al. |
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. |
2011 |
Oncol. Rep. |
pmid:21152868
|
Androutsopoulos VP and Spandidos DA |
Antiproliferative effects of TSA, PXD‑101 and MS‑275 in A2780 and MCF7 cells: Acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity. |
2017 |
Oncol. Rep. |
pmid:29039546
|
Puppin C et al. |
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. |
2011 |
Oncol. Rep. |
pmid:21617864
|
Seo JS et al. |
Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. |
2008 |
Oncol. Rep. |
pmid:18097580
|
Meng CF et al. |
Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. |
2009 |
Oncol. Rep. |
pmid:19787243
|